1. Home
  2. VINC vs DPRO Comparison

VINC vs DPRO Comparison

Compare VINC & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VINC
  • DPRO
  • Stock Information
  • Founded
  • VINC 2019
  • DPRO 1998
  • Country
  • VINC United States
  • DPRO Canada
  • Employees
  • VINC N/A
  • DPRO N/A
  • Industry
  • VINC Biotechnology: Pharmaceutical Preparations
  • DPRO Aerospace
  • Sector
  • VINC Health Care
  • DPRO Industrials
  • Exchange
  • VINC Nasdaq
  • DPRO Nasdaq
  • Market Cap
  • VINC 10.7M
  • DPRO 9.3M
  • IPO Year
  • VINC N/A
  • DPRO N/A
  • Fundamental
  • Price
  • VINC $0.30
  • DPRO $2.23
  • Analyst Decision
  • VINC Buy
  • DPRO Strong Buy
  • Analyst Count
  • VINC 2
  • DPRO 2
  • Target Price
  • VINC $2.00
  • DPRO $7.00
  • AVG Volume (30 Days)
  • VINC 354.0K
  • DPRO 58.9K
  • Earning Date
  • VINC 11-12-2024
  • DPRO 11-14-2024
  • Dividend Yield
  • VINC N/A
  • DPRO N/A
  • EPS Growth
  • VINC N/A
  • DPRO N/A
  • EPS
  • VINC N/A
  • DPRO N/A
  • Revenue
  • VINC N/A
  • DPRO $4,469,286.00
  • Revenue This Year
  • VINC N/A
  • DPRO $30.90
  • Revenue Next Year
  • VINC N/A
  • DPRO $112.38
  • P/E Ratio
  • VINC N/A
  • DPRO N/A
  • Revenue Growth
  • VINC N/A
  • DPRO N/A
  • 52 Week Low
  • VINC $0.29
  • DPRO $1.55
  • 52 Week High
  • VINC $9.37
  • DPRO $15.00
  • Technical
  • Relative Strength Index (RSI)
  • VINC 28.28
  • DPRO 41.73
  • Support Level
  • VINC $0.29
  • DPRO $2.25
  • Resistance Level
  • VINC $0.38
  • DPRO $2.91
  • Average True Range (ATR)
  • VINC 0.03
  • DPRO 0.27
  • MACD
  • VINC 0.01
  • DPRO 0.01
  • Stochastic Oscillator
  • VINC 7.00
  • DPRO 25.59

About VINC Vincerx Pharma Inc.

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: